Eurobio Scientific Valuation
| ALERS Stock | 25.75 0.05 0.19% |
At this time, the firm appears to be overvalued. Eurobio Scientific shows a prevailing Real Value of USD21.47 per share. The current price of the firm is USD25.75. Our model computes the value of Eurobio Scientific from reviewing the firm fundamentals such as Current Valuation of 124.11 M, profit margin of 0.27 %, and Shares Outstanding of 11.34 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Eurobio Scientific's price fluctuation is very steady at this time. Calculation of the real value of Eurobio Scientific is based on 3 months time horizon. Increasing Eurobio Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Eurobio Scientific's intrinsic value may or may not be the same as its current market price of 25.75, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.75 | Real 21.47 | Hype 25.75 | Naive 25.86 |
The intrinsic value of Eurobio Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Eurobio Scientific's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Eurobio Scientific SA helps investors to forecast how Eurobio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eurobio Scientific more accurately as focusing exclusively on Eurobio Scientific's fundamentals will not take into account other important factors: Eurobio Scientific Total Value Analysis
Eurobio Scientific SA is presently projected to have takeover price of 124.11 M with market capitalization of 205.71 M, debt of 11.11 M, and cash on hands of 102.39 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Eurobio Scientific fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
124.11 M | 205.71 M | 11.11 M | 102.39 M |
Eurobio Scientific Investor Information
About 31.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.31. Some equities with similar Price to Book (P/B) outperform the market in the long run. Eurobio Scientific had not issued any dividends in recent years. The entity had 1:20 split on the 1st of September 2017. Based on the measurements of operating efficiency obtained from Eurobio Scientific's historical financial statements, Eurobio Scientific SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Eurobio Scientific Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Eurobio Scientific has an asset utilization ratio of 88.3 percent. This connotes that the Company is making USD0.88 for each dollar of assets. An increasing asset utilization means that Eurobio Scientific SA is more efficient with each dollar of assets it utilizes for everyday operations.Eurobio Scientific Ownership Allocation
The market capitalization of Eurobio Scientific is USD205.71 Million. Eurobio Scientific SA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Eurobio Scientific Profitability Analysis
The company reported the revenue of 185.32 M. Net Income was 60.54 M with profit before overhead, payroll, taxes, and interest of 99.41 M.About Eurobio Scientific Valuation
The stock valuation mechanism determines Eurobio Scientific's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Eurobio Scientific based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eurobio Scientific. We calculate exposure to Eurobio Scientific's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Eurobio Scientific's related companies.8 Steps to conduct Eurobio Scientific's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Eurobio Scientific's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Eurobio Scientific's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Eurobio Scientific's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Eurobio Scientific's revenue streams: Identify Eurobio Scientific's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Eurobio Scientific's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Eurobio Scientific's growth potential: Evaluate Eurobio Scientific's management, business model, and growth potential.
- Determine Eurobio Scientific's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Eurobio Scientific's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Eurobio Stock Analysis
When running Eurobio Scientific's price analysis, check to measure Eurobio Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurobio Scientific is operating at the current time. Most of Eurobio Scientific's value examination focuses on studying past and present price action to predict the probability of Eurobio Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurobio Scientific's price. Additionally, you may evaluate how the addition of Eurobio Scientific to your portfolios can decrease your overall portfolio volatility.